EUVIMEDEUVIMED entdecken
Crossref

Telomere recapping prevents pathogenic telomere-to-mitochondrial DNA communication in heart failure

Yinlong Zhao, Xiaolu Bao, Weiyao Xiong, Xin Wan, Qingying Yu, Teng Wang, Andrew C H Chang, Alian Zhang, Peng Zhang, Zhenhao Lin, Han Gao, Yangyang Liu und 8 weitere

Cardiovascular Research · 22.05.2026 · 122 (7) · 935-952

DOI: 10.1093/cvr/cvag077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 06.04.2026. Verfasst von Yinlong Zhao und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. Hauptthemen laut MEDLINE: Heart Failure, Myocytes, Cardiac, Telomere, DNA, Mitochondrial. Die Arbeit nennt 71 Literaturangaben. Gefördert von: National Natural Science Foundation of China, The Program for Professor of Special Appointment, Shanghai Institutions of Higher Learning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Heart failure (HF) remains a highly prevalent condition with current therapeutic options, 5-year survival remains at 50%. Diseased cardiomyocytes have been demonstrated to exhibit telomeric shortening and through DNA damage response (DDR) activation leads to mitochondria dysfunction. How the orchestration between nuclear and mitochondrial transcription systems regulates myocardial function remains elusive. The aim of this study is to test if myocardial telomere re-protection can restore nuclear-mitochondrial balance and offer a strategy for treating HF. Methods and results To re-protect telomeric ends, we designed an adeno-associated virus 9 (AAV9)-mediated delivery system carrying modified human telomerase protein (modhTERTY707F, D868A, JV101) under cardiac troponin T promoter regulation. The modhTERT is engineered to be catalytic inactive, nuclear localized, and bind to telomeric ends to turn off DDR. Telomeric repeat amplification protocol and quantitative fluorescence in situ hybridization assays were used to demonstrate loss of enzymatic function and localization of JV101. Using TPP1-knock out (TPP1KO) U2OS (telomerase-deficient) and human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) lines generated by CRISPR/Cas9 genome editing, we demonstrated that JV101 is recruited by TPP1 through TEL patch to telomeric ends. JV101 restored cardiac function in both Ang II infusion and myocardial ischaemia-reperfusion HF models and in Ang II-stressed hiPSC-CMs. RNA-Seq data suggests that uncapped telomeres activated p53 and using myocardial p53 deficient (p53cKO) mice we demonstrate that telomere-p53-mitochondrial dysfunction is the main signalling pathway driving HF. Molecularly, JV101 treatment silenced p53, rescued both mitochondrial biogenesis as well as prevented mitochondrial DNA N6-methyladenine (m6A) methylation.

Conclusion

Our work establishes the role of telomere-mitochondria DNA signalling during HF progression and provides proof-of-concept of telomere-targeting gene therapy to restore cardiac function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureMyocytes, CardiacTelomereDNA, MitochondrialMitochondria, HeartTelomeraseGenetic TherapyTelomere HomeostasisAnimalsHumansTumor Suppressor Protein p53Disease Models, AnimalMice, Inbred C57BLTroponin TGene Therapy AgentsDependovirusInduced Pluripotent Stem CellsMice, KnockoutPromoter Regions, GeneticSignal TransductionMaleVentricular Function, Left

Stichwörter der Autor:innen

AAVHeart failureMitochondriaTelomeremtDNA m6A

Substanzen

DNA, MitochondrialTumor Suppressor Protein p53TelomeraseTrp53 protein, mouseTroponin TTP53 protein, human

Autor:innen und Institutionen

  • Department of Cardiology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • Shanghai Institute of Precision Medicine, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • Juvensis Therapeutics, Shanghai, China.
  • Department of Medicine, Division of Cardiology, Stanford University, Palo Alto, CA, USA.
  • Department of Biomedical Engineering, School of Medicine and School of Engineering, University of Alabama at Birmingham, Birmingham, AL 94309, USA.
  • Department of Heart Failure, Heart Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China.

ORCID-Profile: Jianyi Zhang, Alex C Y Chang

Förderung

  • National Natural Science Foundation of China
  • The Program for Professor of Special Appointment
  • Shanghai Institutions of Higher Learning
  • Shanghai Science and Technology Program

Zitieren

APA

Zhao, Y., Bao, X., Xiong, W., Wan, X., Yu, Q., Wang, T., Chang, A. C. H., Zhang, A., Zhang, P., Lin, Z., Gao, H., Liu, Y., Wang, Y., Shang, C., Ashley, E. A., Lei, M., Zhang, J., Zhang, J., Han, W., & Chang, A. C. Y. (2026). Telomere recapping prevents pathogenic telomere-to-mitochondrial DNA communication in heart failure. Cardiovascular Research, 122(7), 935-952. https://doi.org/10.1093/cvr/cvag077

Vancouver

Zhao Y, Bao X, Xiong W, Wan X, Yu Q, Wang T, et al. Telomere recapping prevents pathogenic telomere-to-mitochondrial DNA communication in heart failure. Cardiovascular Research. 2026;122(7):935-952. doi:10.1093/cvr/cvag077

BibTeX
@article{Zhao2026,
  author = {Zhao, Yinlong and Bao, Xiaolu and Xiong, Weiyao and Wan, Xin and Yu, Qingying and Wang, Teng and Chang, Andrew C H and Zhang, Alian and Zhang, Peng and Lin, Zhenhao and Gao, Han and Liu, Yangyang and Wang, Yanqiu and Shang, Ching and Ashley, Euan A and Lei, Ming and Zhang, Jianyi and Zhang, Junfeng and Han, Wei and Chang, Alex C Y},
  title = {Telomere recapping prevents pathogenic telomere-to-mitochondrial DNA communication in heart failure},
  journal = {Cardiovascular Research},
  year = {2026},
  volume = {122},
  number = {7},
  pages = {935--952},
  doi = {10.1093/cvr/cvag077}
}
Kostenlos starten →